Semi-Annual Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7603167

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Semi-annual statement of income
Statement of income
Net sales
105,534,000,000 JPY
102,904,000,000 JPY
Cost of sales
56,093,000,000 JPY
51,276,000,000 JPY
Ordinary profit (loss)
5,569,000,000 JPY
3,960,000,000 JPY
6,447,000,000 JPY
4,585,000,000 JPY
Gross profit (loss)
49,441,000,000 JPY
51,627,000,000 JPY
Extraordinary income
0 JPY
1,929,000,000 JPY
Selling, general and administrative expenses
44,433,000,000 JPY
45,841,000,000 JPY
Extraordinary losses
352,000,000 JPY
0 JPY
25,000,000 JPY
0 JPY
Selling, general and administrative expenses
Advertising expenses
2,063,000,000 JPY
77,000,000 JPY
2,054,000,000 JPY
87,000,000 JPY
Remuneration for directors (and other officers)
266,000,000 JPY
320,000,000 JPY
Depreciation
243,000,000 JPY
223,000,000 JPY
Profit (loss) before income taxes
5,216,000,000 JPY
3,959,000,000 JPY
8,352,000,000 JPY
4,585,000,000 JPY
Operating profit (loss)
5,007,000,000 JPY
4,046,000,000 JPY
5,786,000,000 JPY
4,685,000,000 JPY
Income taxes - current
1,630,000,000 JPY
45,000,000 JPY
1,847,000,000 JPY
60,000,000 JPY
Non-operating income
677,000,000 JPY
83,000,000 JPY
798,000,000 JPY
70,000,000 JPY
Income taxes - deferred
-346,000,000 JPY
-5,000,000 JPY
374,000,000 JPY
8,000,000 JPY
Non-operating income
Interest income
2,000,000 JPY
15,000,000 JPY
Dividend income
408,000,000 JPY
405,000,000 JPY
Non-operating expenses
115,000,000 JPY
170,000,000 JPY
137,000,000 JPY
171,000,000 JPY
Income taxes
1,284,000,000 JPY
40,000,000 JPY
2,222,000,000 JPY
68,000,000 JPY
Profit (loss)
3,919,000,000 JPY
3,919,000,000 JPY
3,919,000,000 JPY
3,932,000,000 JPY
3,919,000,000 JPY
4,516,000,000 JPY
4,516,000,000 JPY
6,130,000,000 JPY
4,516,000,000 JPY
4,516,000,000 JPY
Non-operating expenses
Interest expenses
66,000,000 JPY
68,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
0 JPY
367,000,000 JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.